Granata Bio Featured in Clarivate for Life Sciences & Healthcare’s Companies to Watch: Rediscovering Women’s Health Report

Clarivate for Life Sciences & Healthcare released its latest Companies to Watch report, Rediscovering Women's Health, highlighting seven companies, including Granata Bio, driving innovation across reproductive care, chronic disease, and mental health. Drawing on proprietary data, expert analysis, and insights into therapeutic impact, financing activity, and R&D momentum, the report showcases why these companies are recognized as high-impact innovators.

Despite representing half the global population, women remain underrepresented in clinical research and healthcare investment, with women's health accounting for just 15% of venture capital and 5% of global healthcare R&D funding. Rediscovering Women's Health highlights organizations addressing these gaps through inclusive research, novel therapies, and a deeper understanding of female-specific conditions such as early menopause, polycystic ovary syndrome (PCOS), and endometriosis. The report also highlights growing momentum in women's health R&D.

Greater awareness, stronger regulatory frameworks supporting sexual health equity, and increasing financial investment are accelerating progress in women's health. These developments create meaningful opportunities for the pharmaceutical industry to help close long-standing gaps and address unmet health needs for women worldwide.

Learn more about how Granata Bio is reimagining what’s possible in reproductive health, and the six other companies shaping the future of women's health, in the full Companies to Watch report, Rediscovering Women's Health, here.